This inventor holds 1 USPTO granted patent and 10 published patent applications and 2 EPO patents. Top assignee: E-Therapeutics Plc. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: James Longden - Innovator in Diabetes Treatment
Introduction
James Longden is a notable inventor based in Maidenhead, GB. He has made significant contributions to the field of diabetes treatment through his innovative work. With a focus on inhibitors and their applications, Longden's research has the potential to impact many lives.
Latest Patents
James Longden holds 1 patent related to his work on inhibitors of expression and/or function. This patent addresses the development of inhibitors and compositions that can be used in the treatment or prevention of diabetes. His invention represents a promising advancement in medical science.
Career Highlights
Throughout his career, Longden has worked with several companies, including E-Therapeutics Plc and Tangram Therapeutics Plc. His experience in these organizations has allowed him to refine his skills and contribute to important projects in the healthcare sector.
Collaborations
James Longden has collaborated with notable professionals in his field, including Duncan Brown and Graham Craggs. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
James Longden is a dedicated inventor whose work in diabetes treatment showcases his commitment to improving healthcare. His contributions through patents and collaborations highlight the importance of innovation in addressing medical challenges.